Permanent pacemaker implantation following mitral valve surgery: a retrospective cohort study of risk factors and

Mark R Helmers1, Max Shin1, Amit Iyengar1

  • 1Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA.

Abstract

Insights

Permanent pacemaker (PPM) implantation after mitral valve surgery (MVS) is linked to older age and additional procedures. While PPM is associated with survival, it does not independently predict mortality.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Electrophysiology

Background:

  • Permanent pacemaker (PPM) implantation is a known complication of valvular surgery.
  • PPMs carry risks including infection, tricuspid valve regurgitation, and pacing-induced cardiomyopathy.
  • Limited literature exists on PPM placement specifically in mitral valve surgery (MVS).

Purpose of the Study:

  • To identify predictors of PPM implantation following MVS.
  • To assess the association between PPM implantation and long-term survival after MVS.

Main Methods:

  • Retrospective review of adult patients undergoing MVS from 2011-2019.
  • Stratification based on PPM receipt post-surgery; exclusion of patients with preoperative PPM.
  • Multivariable logistic regression and Cox proportional hazards models were used to identify risk factors and survival associations.

Main Results:

  • Significant predictors for PPM included increasing age, concomitant aortic and tricuspid valve procedures, and prior myocardial infarction.
  • In isolated MV repair, annuloplasty with a ring prosthesis increased PPM risk compared to a band.
  • No significant survival difference was found, and PPM was not an independent predictor of mortality.

Conclusions:

  • Increasing age and concomitant procedures are key predictors for PPM implantation in MVS.
  • PPM implantation is associated with worse long-term survival but does not independently predict mortality.
  • Annuloplasty ring use in isolated MV repair is linked to higher PPM rates.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
159
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
108
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
126
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
153
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
121
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
82